Back to results
US 8,895,304 B2Granted
Hemostatic device
AssigneeACell, Inc.
InventorsClay Fette, Abram Janis, Benjamin Kibalo
Life of this patent
Estimating the term…
Abstract
A hemostatic device, method of making, and method of using for internal and external applications to wounds in the body of a patient to induce hemostasis at an anatomical site.
Claims21
A bioresorbable composition, comprising:
- (i) a compressed, dehydrated, particularized, extracellular matrix material (ECM) comprising non-cross-linked ECM components isolated in their native configuration, said non-cross-linked ECM components selected from the group consisting of collagen type IV, collagen type VII, glycosaminoglycans, fibronectin, and laminin, said ECM comprising epithelial basement membrane and one or more layers of an epithelial tissue selected from the group consisting of tunica propria, tunica submucosa, and tunica muscularis derived from a mammalian epithelial tissue;
- and,
- (ii) a sheet like backing comprising an ECM that is applied to the surface of the ECM of (i).
Dependencies are inferred from the claim text.